» Articles » PMID: 30155007

Conformational Changes in Amyloid-beta (12-28) Alloforms Studied Using Action-FRET, IMS and Molecular Dynamics Simulations

Overview
Journal Chem Sci
Specialty Chemistry
Date 2018 Aug 30
PMID 30155007
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Small oligomers of the amyloid beta protein (Aβ) have been implicated as the neurotoxic agent leading to Alzheimer's disease, and in particular mutations in the hydrophobic core region comprising amino acids L17 to A21 have a large influence on the propensity for aggregate formation. It has been shown that the F19P alloform of Aβ forms small aggregates, but does not proceed to form large fibrils and plaques. In order to understand the origin of this behavior, the gas phase conformations for the different charge states of the wild-type 12-28 fragment of the amyloid beta and its F19P alloform were studied by a combination of action-FRET, ion-mobility spectrometry (IMS) and molecular dynamics simulations. Comparison of the experimental and theoretical action-FRET efficiencies and collision cross sections allowed the determination of the lowest energy conformational family for each alloform and charge state. For both alloforms, it was found that there is a change from globular to helical structure between the 3+ and 4+ charge states. Additional protonation to give 5+ and 6+ charge states caused unfolding of this helical motif, with the wild alloform showing β-turn like motifs and the F19P alloform random coil motifs. The presence of the helical to β-turn structural transition in the wild, but not the F19P, alloform may help to elucidate the origin of the large difference in aggregation behavior of the two alloforms.

Citing Articles

Determining the gas-phase structures of α-helical peptides from shape, microsolvation, and intramolecular distance data.

Wu R, Metternich J, Kamenik A, Tiwari P, Harrison J, Kessen D Nat Commun. 2023; 14(1):2913.

PMID: 37217470 PMC: 10203302. DOI: 10.1038/s41467-023-38463-z.


Separation of β-Amyloid Tryptic Peptide Species with Isomerized and Racemized l-Aspartic Residues with Ion Mobility in Structures for Lossless Ion Manipulations.

Nagy G, Kedia K, Attah I, Garimella S, Ibrahim Y, Petyuk V Anal Chem. 2019; 91(7):4374-4380.

PMID: 30816701 PMC: 6596305. DOI: 10.1021/acs.analchem.8b04696.


The application of ion-mobility mass spectrometry for structure/function investigation of protein complexes.

Ben-Nissan G, Sharon M Curr Opin Chem Biol. 2017; 42:25-33.

PMID: 29128665 PMC: 5796646. DOI: 10.1016/j.cbpa.2017.10.026.


Visible Multiphoton Dissociation of Chromophore-Tagged Peptides.

Bouakil M, Kulesza A, Daly S, MacAleese L, Antoine R, Dugourd P J Am Soc Mass Spectrom. 2017; 28(10):2181-2188.

PMID: 28755260 PMC: 5594054. DOI: 10.1007/s13361-017-1733-9.


Ion Mobility Collision Cross Section Compendium.

May J, Morris C, McLean J Anal Chem. 2016; 89(2):1032-1044.

PMID: 28035808 PMC: 5744664. DOI: 10.1021/acs.analchem.6b04905.


References
1.
BURDICK D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A . Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem. 1992; 267(1):546-54. View

2.
Fraser P, Nguyen J, Surewicz W, Kirschner D . pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J. 1991; 60(5):1190-201. PMC: 1260174. DOI: 10.1016/S0006-3495(91)82154-3. View

3.
Kirkitadze M, Bitan G, Teplow D . Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res. 2002; 69(5):567-77. DOI: 10.1002/jnr.10328. View

4.
Bernstein S, Dupuis N, Lazo N, Wyttenbach T, Condron M, Bitan G . Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem. 2010; 1(4):326-31. PMC: 2918915. DOI: 10.1038/nchem.247. View

5.
Peralvarez-Marin A, Mateos L, Zhang C, Singh S, Cedazo-Minguez A, Visa N . Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer's amyloid beta peptide. Biophys J. 2009; 97(1):277-85. PMC: 2711388. DOI: 10.1016/j.bpj.2009.04.017. View